Is DNA Markets a Scam?

At FXCanary, our safety assessment is built on a structured framework that weighs regulatory oversight, client-fund protection, corporate transparency, and the real-world experience of traders. We cross-check every licence against the public register, verify the registered entity and address, and look for red flags such as clone sites, unresolved complaints, and gaps in disclosure. For a broker with no independent user reviews yet, the absence of direct feedback is itself a signal: we must rely even more heavily on the regulatory record and the structural safeguards in place.

For DNA Markets, our Scam Risk Score is 36 out of 100, which we classify as 'Guarded'. This is not a verdict of fraud, but a clear warning that the broker carries a moderate level of risk, and that traders should proceed with caution. The score is built from several components, including the regulatory status, the presence of a clone site, and a risk flag indicating withdrawal complaints in roughly 18% of recent reviews we have aggregated from industry databases. While we cannot verify the specifics of those complaints without independent user reviews, the pattern is consistent enough to warrant attention.

DNA Markets is the trading name of Focus Markets Pty Ltd, a company registered in Australia. Our records show the broker holds one licence from the Australian Securities and Investments Commission (ASIC), with the licence number 514425, for Market Making (MM) activities. ASIC is one of the most respected financial regulators globally, and holding an ASIC licence is a meaningful positive signal. It means the broker is subject to Australian financial services laws, including obligations around conduct, disclosure, and dispute resolution.

However, we must be precise about what an ASIC licence does and does not guarantee. ASIC does not operate a compensation scheme for retail clients in the way that, for example, the UK's Financial Services Compensation Scheme does. If the broker fails, client funds are not automatically protected by a government-backed payout. ASIC does require that client money be held in segregated accounts, which is a critical safeguard, but segregation is not the same as insurance. In our assessment, the ASIC licence provides a solid baseline of oversight, but traders should not assume the same level of protection they might expect in other jurisdictions.

ASIC's client money rules require that retail client funds be held in separate accounts, distinct from the broker's own operating funds. This is a fundamental protection: in the event of insolvency, client money should not be treated as part of the broker's assets. We have no evidence to suggest that DNA Markets is not complying with this requirement, and we would expect an ASIC-regulated entity to do so. Still, we have not been able to independently verify the exact banking arrangements, and the broker's own disclosures on this point are not detailed in our records.

Negative balance protection is another area where traders need to be clear-eyed. ASIC has imposed leverage limits on retail clients, but it does not mandate negative balance protection in the same way that European regulators do under ESMA rules. This means that in volatile markets, a trader could potentially lose more than their deposited funds if the broker does not offer negative balance protection as a policy. We have no information on whether DNA Markets provides this feature, and we would strongly advise traders to confirm this directly with the broker before trading. In our view, the absence of clear, published information on these protections is a gap that traders should treat as a caution.

Our records indicate that there is at least one clone or impersonator site associated with the DNA Markets name. This is a significant red flag. Clone sites are a common tactic used by fraudsters to lure traders into depositing funds with an unregulated entity that mimics a legitimate broker. They often copy the branding, website design, and even the regulatory claims of the real broker, making it difficult for an average trader to distinguish the fake from the real.

For DNA Markets, the existence of a clone site means that traders must be extra vigilant. We strongly recommend that you only access the broker through the official domain, dnamarkets.com, and that you verify this address directly from the regulator's own records if possible. Never click on links from unsolicited emails, social media ads, or third-party websites that claim to be DNA Markets. If you are unsure, contact the broker directly using the contact details on the official site, and independently confirm any account details before sending funds. In our assessment, the presence of a clone site elevates the risk profile of the broker, even if the legitimate entity is properly regulated.

DNA Markets was founded on 29 November 2022, and is registered at a professional address in Melbourne: South Tower, Level 35, 525 Collins Street, VIC 3000. The company, Focus Markets Pty Ltd, is the legal entity behind the trading name. We have no information on the number of employees, which is listed as zero in our records—this is unusual and may indicate that the company is a small operation or that the data is incomplete. A lack of public information about key personnel and operational scale is a common feature of brokers that have not yet built a long track record.

We also note that the broker's own description claims it was 'established in 2023', while our records show a registration date in late 2022. This slight discrepancy is not necessarily alarming, but it highlights the importance of checking official records rather than relying on marketing materials. In our assessment, the broker appears to be a relatively new entrant to the market, and while new does not mean unsafe, it does mean there is less historical data to evaluate. Traders should weigh this limited track record against the regulatory oversight that ASIC provides.

Our aggregated industry data shows a risk flag indicating that withdrawal complaints appear in approximately 18% of recent reviews for DNA Markets. This is a notable percentage, and it is the primary driver of the 'Guarded' risk score. Withdrawal issues are among the most serious problems a trader can face, as they directly affect access to your own money. However, we must be careful in interpreting this data: the reviews are aggregated from industry databases, and we have not been able to independently verify the specifics of each complaint. The sample size may be small, and the complaints could stem from the clone site rather than the legitimate broker.

Nevertheless, a pattern of withdrawal complaints, even at 18%, is a signal that we cannot ignore. We would advise traders to test the withdrawal process with a small amount before committing significant funds, and to keep detailed records of all transactions. If you do encounter a delay or refusal to process a withdrawal, you should escalate the issue through the broker's formal complaints procedure, and if necessary, contact ASIC or the Australian Financial Complaints Authority (AFCA) if the broker is a member. In our view, this is the most concrete risk factor in the safety profile of DNA Markets.

Given the guarded risk score, the clone site, and the withdrawal complaints, we recommend a cautious approach for anyone considering DNA Markets. First, verify the broker's identity and licence directly on the ASIC register. You can search for 'Focus Markets Pty Ltd' and confirm the licence number 514425 and the official domain.

Never rely solely on the broker's website or promotional materials. Second, start with a small deposit that you can afford to lose, and test both the deposit and withdrawal processes before increasing your exposure. This is a prudent step for any new broker, but especially for one with a limited track record.

Third, be extremely wary of any website or communication that claims to be DNA Markets but does not use the exact domain dnamarkets.com. Clone sites are a real threat, and the safest way to protect yourself is to bookmark the official URL and always access it directly. Fourth, keep records of all communications, trade confirmations, and financial transactions.

If a dispute arises, you will need this documentation to support your case. Finally, consider whether the broker's offerings—such as over 800 instruments and tight spreads—are worth the risks. If you are not comfortable with the level of uncertainty, there are many other ASIC-regulated brokers with longer histories and more transparent operations.

In FXCanary's assessment, DNA Markets is not an obvious scam, but it is not a broker we would wholeheartedly endorse either. The ASIC licence is a genuine positive, and the use of a real corporate entity with a physical address is reassuring. However, the lack of independent user reviews, the presence of a clone site, and the withdrawal complaint flag all contribute to a 'Guarded' score of 36/100. We cannot give this broker a clean bill of health, and we would urge traders to apply the protective measures outlined above.

We also note that the broker's own claims—such as fast execution and competitive pricing—are marketing statements that we have not independently verified. As with any broker, we recommend that you conduct your own due diligence, read the terms and conditions carefully, and never invest money you cannot afford to lose. The safety picture for DNA Markets is still evolving, and we will continue to monitor the broker as more data becomes available. For now, caution is the watchword.